• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » WCG’s Safety Compliance Platform Goes Live

WCG’s Safety Compliance Platform Goes Live

February 7, 2022

WCG has launched Total Safety, an end-to-end solution for case processing, aggregate safety reporting, drug safety and safety letter distribution.

The system is designed to reduce burden on sites imposed by safety document reviews and helps up-and-coming biopharma companies avoid having to create their own internal drug safety systems. In addition, Total Safety stores data from study sites and CROs in a single safety database in real-time.

“We have reengineered the industry’s status quo safety management process — which is intricate, onerous and risky — and simplified it in a manner that facilitates increased protections for patients, stronger regulatory compliance and less burden on investigators and staff in the clinical trial process,” Nicholas Slack, president of WCG, said. “Leaving safety to chance is a risky proposition for all organizations, especially earlier-stage biopharmaceutical companies.”

According to WCG, the full system has not been released until now, but clients have used components of the Total Safety solution previously and seen noteworthy results, including $40,000 saved per study on average and reductions of up to 50 percent on unnecessary safety reports.

 

To view more CenterWatch Weekly stories, click here.

    Upcoming Events

    • 16Oct

      MAGI@home Clinical Research Conference 2023

    • 25Oct

      2023 WCG Patient Forum

    • 26Oct

      FDA in 2024: What to Expect in an Election Year

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Donna Snyder

      New WCG Executive Physician Outlines Goals for Clinical Research

    • Hand Shake at Meeting

      Partnership to Bolster Trials in Low Resource Regions Kicks Off

    • Guidelines-360x240.png

      Major Industry Groups Offer Feedback on ICH’s E6(R3) Guidelines

    • AsktheExpertsBadge-360x240.png

      Ask the Experts: Monitoring

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing